Gefitinib 250mg Tablet (Gefititaj) – Long Product Description

Gefitinib 250mg Tablet (Gefititaj) – Effective Targeted Therapy for EGFR-Positive Lung Cancer

Gefitinib 250mg Tablet (Gefititaj) is a targeted anti-cancer medicine containing Gefitinib 250mg, a tyrosine kinase inhibitor (TKI) used for the treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC). It works by blocking the epidermal growth factor receptor (EGFR), slowing or stopping the growth and spread of cancer cells.

Manufactured by Sartaj Pharma, Gefititaj 250mg Tablet is supplied in a pack of 30 tablets and is prescribed by oncologists for eligible patients diagnosed with advanced or metastatic NSCLC.

---

Key Features of Gefititaj 250mg Tablet

• Contains Gefitinib 250mg
• Manufactured by Sartaj Pharma
• Pack Size: 30 Tablets
• Oral targeted therapy for lung cancer
• Specifically indicated for EGFR mutation-positive NSCLC
• Convenient once-daily dosing
• Helps delay cancer progression
• Prescription-only anti-cancer medicine

---

What is Gefitinib 250mg Tablet?

Gefitinib belongs to a class of medicines called epidermal growth factor receptor (EGFR) inhibitors. Certain lung cancers depend on EGFR signaling to grow and spread. Gefitinib blocks this pathway, preventing cancer cells from multiplying and encouraging their destruction.

Because this medicine targets specific cancer cells, it generally causes fewer side effects than conventional chemotherapy in appropriately selected patients.

---

Uses of Gefititaj 250mg Tablet

Gefitinib 250mg Tablet is primarily used for:

• Treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC)
• Advanced or metastatic lung cancer
• First-line therapy for eligible patients
• Patients whose tumors have activating EGFR mutations
• Long-term targeted treatment under oncologist supervision

---

How Gefitinib Works

Gefitinib inhibits the activity of the EGFR tyrosine kinase enzyme, which plays an important role in cancer cell growth.

By blocking EGFR:

• Cancer cell multiplication slows down.
• Tumor growth is reduced.
• Spread of cancer may be delayed.
• Patients may experience improved progression-free survival.

---

Dosage and Administration

The usual recommended dosage is:

• One Gefitinib 250mg Tablet once daily
• Take with or without food.
• Swallow the tablet whole with water.
• Take it at the same time every day.
• Continue treatment exactly as prescribed by your oncologist.

Never increase, decrease, or stop treatment without medical advice.

---

Possible Side Effects

Like all medicines, Gefitinib may cause side effects.

Common side effects include:

• Skin rash
• Dry skin
• Acne-like eruptions
• Diarrhea
• Nausea
• Loss of appetite
• Mouth sores
• Fatigue
• Nail changes
• Mild liver enzyme elevation

Serious side effects requiring immediate medical attention include:

• Difficulty breathing
• Persistent cough
• Fever
• Severe diarrhea
• Vision changes
• Severe allergic reactions
• Liver problems
• Signs of interstitial lung disease (ILD)

Inform your doctor immediately if any severe symptoms occur.

---

Precautions and Warnings

Before using Gefititaj 250mg Tablet:

• Inform your doctor about any liver or kidney disease.
• Tell your doctor if you have lung disorders.
• Discuss all medicines, vitamins, and herbal supplements you are taking.
• Avoid self-medication during treatment.
• Regular blood tests may be required.
• Liver function should be monitored periodically.
• Avoid smoking, as it may affect treatment outcomes.

---

Contraindications

Gefitinib should not be used in patients who:

• Are allergic to Gefitinib or any ingredient in the tablet.
• Have severe hypersensitivity reactions to this medicine.
• Are advised against its use by their oncologist due to underlying medical conditions.

---

Pregnancy and Breastfeeding

Gefitinib may harm an unborn baby.

• Avoid use during pregnancy unless specifically prescribed.
• Effective contraception is recommended during treatment.
• Breastfeeding should be avoided while taking Gefitinib and for a period after treatment, as advised by your doctor.

---

Drug Interactions

Gefitinib may interact with:

• Proton pump inhibitors (PPIs)
• H2 receptor blockers
• Antacids
• Warfarin
• Rifampicin
• Phenytoin
• Carbamazepine
• St. John’s Wort
• Strong CYP3A4 inducers or inhibitors

Always inform your healthcare provider about all medicines you are taking.

---

Storage Instructions

• Store below 30°C.
• Keep in the original packaging.
• Protect from heat and moisture.
• Keep away from children and pets.

---

Price of Gefitinib 250mg Tablet in Pakistan

The price of Gefititaj 250mg Tablet may vary depending on availability, supplier, and location in Pakistan.

For the latest price, genuine products, and nationwide delivery, visit MedicineWalyDost.com or contact customer support before placing your order.

---

Why Buy Gefititaj 250mg Tablet from MedicineWalyDost.com?

MedicineWalyDost.com offers:

• Genuine oncology medicines
• Competitive prices
• Nationwide delivery across Pakistan
• Secure ordering process
• Trusted pharmaceutical products
• Professional customer support

Always purchase prescription medicines from reliable and authorized suppliers.

---

Frequently Asked Questions (FAQs)

What is Gefititaj 250mg Tablet used for?

It is used to treat EGFR mutation-positive non-small cell lung cancer (NSCLC) under the supervision of an oncologist.

How should I take Gefitinib 250mg?

Take one tablet once daily, exactly as prescribed by your doctor.

Can Gefitinib cure lung cancer?

Gefitinib is designed to control cancer progression and improve outcomes in eligible patients, but treatment goals vary depending on the individual’s condition.

Can I stop taking Gefitinib if I feel better?

No. Continue treatment unless your oncologist advises otherwise.

Is Gefitinib chemotherapy?

No. Gefitinib is a targeted therapy, not traditional chemotherapy.

Do I need regular monitoring during treatment?

Yes. Your doctor may recommend blood tests, liver function tests, and regular clinical assessments during therapy.